abraxane,paclitaxel
amgen
['sequence,(-consequence)', 'pancreatic']
ph 2 sequence trial: alternated nabgem-folfox vs standard nabgem as 1l treatment in advanced pancreatic cancer mos 13.2 vs 9.7 mo (hr 0.67) more g3-4 neutropenia, thrombocytopenia #asco22 
??Medical Oncologist, MSc, PhD. GI/neuroendocrine/GU tumors/breast cancer ??Hospital Universitario UFC-CE, Oncologia D’Or